Suppr超能文献

胞质型磷脂酶A2

Cytosolic phospholipase A2.

作者信息

Clark J D, Schievella A R, Nalefski E A, Lin L L

机构信息

Small Molecule Drug Discovery Group, Genetics Institute, Cambridge, MA 0214, USA.

出版信息

J Lipid Mediat Cell Signal. 1995 Oct;12(2-3):83-117. doi: 10.1016/0929-7855(95)00012-f.

Abstract

To summarize the regulation of cPLA2, we have proposed a model for the activation of cPLA2 based both on our previous studies (Clark et al., 1991; Lin et al., 1993) and the work of many others (Fig. 5). In this model, cPLA2 is tightly regulated by multiple pathways, including those that control Ca2+ concentration, phosphorylation states and cPLA2 protein levels, to exert both rapid and prolonged effects on cellular processes, such as inflammation. cPLA2 is rapidly activated by increased intracellular Ca2+ concentration and phosphorylation by MAP kinase. When cells are stimulated with a ligand for a receptor, such as ATP or PDGF, PLC is activated via either a G protein-dependent or -independent process, leading to the production of diacylglycerol (DAG) and inositol triphosphate (IP3). The rise in these intracellular messengers cause the activation of PKC and mobilization of intracellular Ca2+. Alternatively, the increase in intracellular Ca2+ can result from a Ca2+ influx. Increased Ca2+ acts through the CaLB domain to cause translocation of cPLA2 from the cytosol to the membrane where its substrate, phospholipid, is localized. This step is essential for the activation of cPLA2 and may account for the partial activation of cPLA2 in the absence of phosphorylation. MAP kinase activation can occur through both PKC-dependent and -independent mechanisms (Cobb et al., 1991; Posada and Cooper, 1992; Qiu and Leslie, 1994). In many cases, this pathway is also G protein-dependent. Activated MAP kinase phosphorylates cPLA2 at Ser-505, causing increased enzymatic activity of cPLA2, which is realized only upon translocation of cPLA2 to the membrane. Therefore, full activation of cPLA2 requires both increased cytosolic Ca2+ and cPLA2 phosphorylation at Ser-505. In a more delayed response, cPLA2 activity in the cells can be controlled by changes in its expression levels, such as in response to inflammatory cytokines and certain growth factors. Thus the expression level of cPLA2 is regulated by both transcriptional and post-transcriptional mechanisms.

摘要

为总结cPLA2的调控机制,我们基于之前的研究(Clark等人,1991年;Lin等人,1993年)以及其他许多人的工作成果,提出了一个cPLA2激活模型(图5)。在这个模型中,cPLA2受到多种途径的严格调控,包括那些控制钙离子浓度、磷酸化状态和cPLA2蛋白水平的途径,从而对细胞过程(如炎症)产生快速和持久的影响。细胞内钙离子浓度升高和丝裂原活化蛋白激酶(MAP激酶)磷酸化可迅速激活cPLA2。当细胞受到受体配体(如ATP或血小板衍生生长因子)刺激时,磷脂酶C(PLC)通过G蛋白依赖性或非依赖性过程被激活,导致二酰基甘油(DAG)和肌醇三磷酸(IP3)的产生。这些细胞内信使分子的增加会导致蛋白激酶C(PKC)的激活和细胞内钙离子的动员。另外,细胞内钙离子的增加也可能源于钙离子内流。增加的钙离子通过CaLB结构域起作用,导致cPLA2从细胞质转移到其底物磷脂所在的细胞膜。这一步骤对于cPLA2的激活至关重要,并且可能解释了在没有磷酸化的情况下cPLA2的部分激活。MAP激酶的激活可通过PKC依赖性和非依赖性机制发生(Cobb等人,1991年;Posada和Cooper,1992年;Qiu和Leslie,1994年)。在许多情况下,这条途径也是G蛋白依赖性的。激活的MAP激酶在丝氨酸505处磷酸化cPLA2,导致cPLA2的酶活性增加,而这只有在cPLA2转移到细胞膜后才会实现。因此,cPLA2的完全激活需要细胞溶质钙离子的增加和丝氨酸505处的cPLA2磷酸化。在更延迟的反应中,细胞内cPLA2的活性可通过其表达水平的变化来控制,例如对炎症细胞因子和某些生长因子的反应。因此,cPLA2的表达水平受到转录和转录后机制的调控。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验